Note that all amounts presented in the table below are in thousands
of U.S. dollars, except share and par value amounts.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS
1.
|
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
|
Nature of Operations
The
Company designs, markets and distributes branded juvenile health, safety and wellness products that are sold globally to large
national retailers as well as independent retailers, primarily in North America. The Company currently markets its products in
several product categories including safety, nursery, monitoring, and baby gear. Most products are sold under our core brand names
of Summer™, SwaddleMe®, and born free®.
When used herein, the terms the “Company,” “we,” “us,” and “our” mean Summer Infant, Inc.
and its consolidated subsidiaries.
Basis of Presentation and Principles of Consolidation
The accompanying interim condensed consolidated
financial statements of the Company are unaudited, but in the opinion of management, reflect all adjustments, consisting of normal
recurring accruals, necessary for a fair presentation of the results for the interim periods. Accordingly, they do not include
all information and notes required by generally accepted accounting principles in the United States of America (“GAAP”)
for complete financial statements. The results of operations for interim periods are not necessarily indicative of results to be
expected for the entire fiscal year or any other period. The balance sheet at December 28, 2019 has been derived from the
audited financial statements at that date but does not include all of the information and footnotes required by GAAP for complete
financial statements. These interim condensed consolidated financial statements should be read in conjunction with the Company’s
consolidated financial statements and notes for the year ended December 28, 2019 included in its Annual Report on Form 10-K
filed with the SEC on March 18, 2020, as amended on April 24, 2020.
It is the Company’s policy to prepare
its financial statements on the accrual basis of accounting in conformity with GAAP. The interim condensed consolidated financial
statements include the accounts of its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been
eliminated in the consolidation.
All dollar amounts included in the Notes
to Condensed Consolidated Financial Statements are in thousands of U.S. dollars, except share and per share amounts.
In March 2020, the Company completed a 1-for-9
reverse stock split of the Company's issued and outstanding shares of common stock in order to regain compliance with Nasdaq's
minimum bid price requirement. Accordingly, information in the financial statements and accompanying notes included in this Quarterly
Report on Form 10-Q related to fiscal 2019 give effect to the reverse stock split as if it occurred at the beginning of the
first period presented.
Reclassification
Previously reported amounts have been revised
in the accompanying condensed consolidated statement of cash flows to properly state certain right to use assets and lease liabilities.
These revisions had no impact on the company’s net cash provided by or used in operating activites.
Revenue Recognition
The Company recognizes revenue to depict
the transfer of promised goods to customers in an amount that reflects what it expects to receive in exchange for the
goods.
The Company’s principal activities
from which it generates its revenue is product sales. The Company has one reportable segment of business.
Revenue is measured based on consideration
specified in a contract with a customer. The Company recognizes revenue when it satisfies a performance obligation in a contract
by transferring control over a product to a customer when product delivery occurs. Consideration is typically paid approximately
60 days from the time control is transferred. Taxes assessed by a governmental authority that are both imposed on and concurrent
with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue. Shipping
and handling costs associated with outbound freight after control over a product has transferred to a customer are accounted for
as a fulfillment cost and are included in selling costs.
A performance obligation is a promise in
a contract to transfer a distinct product to the customer, which for the Company is transfer of juvenile products to its customers.
The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when or as the
customer receives the benefit of the performance obligation.
A transaction price is the amount of consideration
the Company expects to receive under the arrangement. The Company is required to estimate variable consideration (if any) and to
factor that estimation into the determination of the transaction price. The Company conducts its business with customers through
valid purchase or sales orders each of which is considered a separate contract because individual orders are not interdependent
on one another. Product transaction prices on a purchase or sale order are discrete and stand-alone. Purchase or sales orders may
be issued under either a customer master service agreement or a reseller allowance agreement. Purchase or sales orders, master
service agreements, and reseller allowance agreements, which are specific and unique to each customer, may include product price
discounts, markdown allowances, return allowances, and/or volume rebates which reduce the consideration due from customers. Variable
consideration is estimated using the most likely amount method, which is based on historical experience as well as current information
such as sales forecasts.
Contracts may also include cooperative advertising
arrangements where the Company allows a discount from invoiced product amounts in exchange for customer purchased advertising that
features the Company’s products. These allowances are generally based upon product purchases or specific advertising campaigns.
Such allowances are accrued when the related revenue is recognized. These cooperative advertising arrangements provide a distinct
benefit and fair value and are accounted for as direct selling expenses.
Use of Estimates
The preparation of financial statements
in accordance with GAAP requires management to make estimates and assumptions that affect certain reported amounts of revenues,
expenses, assets, liabilities and related disclosures. These estimates are based on management’s best knowledge as of the
date the financial statements are published of current events and actions the Company may undertake in the future. Accordingly,
actual results could differ from those estimates.
Trade Receivables
Trade receivables are carried at their outstanding
unpaid principal balances reduced by an allowance for doubtful accounts. The Company estimates doubtful accounts based on historical
bad debts, factors related to specific customers’ ability to pay and current economic trends. The Company writes off accounts
receivable against the allowance when a balance is determined to be uncollectible. Amounts are considered to be uncollectable based
upon historical experience and management’s evaluation of outstanding accounts receivable.
Changes in the allowance for doubtful accounts
are as follows:
|
|
For the
three months ended
|
|
|
|
March 28, 2020
|
|
|
March 30, 2019
|
|
Allowance for doubtful accounts, beginning of period
|
|
$
|
542
|
|
|
$
|
304
|
|
Charges to costs and expenses, net
|
|
|
23
|
|
|
|
9
|
|
Account write-offs
|
|
|
—
|
|
|
|
—
|
|
Allowance for doubtful accounts, end of period
|
|
$
|
565
|
|
|
$
|
313
|
|
Inventory Valuation
Inventory is comprised mostly of finished
goods and some component parts and is stated at the lower of cost using the first-in, first-out (“FIFO”) method, or
net realizable value. The Company regularly reviews slow-moving and excess inventories, and writes down inventories to net realizable
value if the expected net proceeds from the disposals of excess inventory are less than the carrying cost of the merchandise.
Leases
The Company determines if an arrangement
is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets and operating
lease liabilities in the Company’s condensed consolidated balance sheets.
ROU assets represent the Company’s
right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present
value of lease payments over the lease term. As the Company’s leases do not provide an implicit rate, the Company’s
uses its incremental borrowing rate based on the information available at commencement date in determining the present value of
lease payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. The Company’s
lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that
option.
The components of a lease should be split
into three categories: lease components (e.g., land, building, etc.), non-lease components (e.g., common area maintenance,
maintenance, consumables, etc.), and non-components (e.g., property taxes, insurance, etc.). Then the fixed and in-substance
fixed contract consideration (including any related to non-components) must be allocated based on fair values to the lease components
and non-lease components. Although separation of lease and non-lease components is required, certain practical expedients are available
to entities. Entities electing the practical expedient would not separate lease and non-lease components. Rather, they would account
for each lease component and the related non-lease component together as a single component. The Company’s facilities operating
leases have lease and non-lease components to which the Company has elected to apply the practical expedient and account for each
lease component and related non-lease component as one single component. The lease component results in a ROU asset being recorded
on the balance sheet. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
Income Taxes
Income taxes are computed using the asset
and liability method of accounting. Under the asset and liability method, a deferred income tax asset or liability is recognized
for estimated future tax effects attributable to temporary differences and carry-forwards. The measurement of deferred income tax
assets is adjusted by a valuation allowance, if necessary, to recognize future tax benefits only to the extent, based on available
evidence, that it is more likely than not that such benefits will be realized. The net deferred tax assets and liabilities are
presented as noncurrent.
The Company utilized the discrete
method of accounting for income taxes in the U.S. for the three months ended March 28, 2020 and the three months ended March
30, 2019 as it believes the discrete method results in a more accurate representation of the income tax benefit for the
quarter.
The Company follows the appropriate guidance
relative to uncertain tax positions. This standard provides detailed guidance for the financial statement recognition, measurement
and disclosure of uncertain tax positions recognized in the financial statements. Uncertain tax positions must meet a recognition
threshold of more-likely-than-not in order for those tax positions to be recognized in the financial statements.
On March 27, 2020, the U.S. CARES Act was enacted, which provided a substantial tax-and-spending package intended to provide
additional economic stimulus to address the impact of the COVID-19 pandemic. The U.S. CARES Act provides numerous tax provisions
and other stimulus measures, including temporary changes regarding the prior and future utilization of net operating losses,
temporary changes to the prior and future limitations on interest deductions, temporary suspension of certain payment requirements
for the employer portion of Social Security taxes, technical corrections from prior tax legislation for tax depreciation of
certain qualified improvement property, and the creation of certain refundable employee retention credits. As a result of
the U.S. CARES Act tax law changes, we recognized a $262 tax benefit related to the increase in interest deduction occurring
during the fiscal year ended December 28, 2019 which was fully reserved for. The impact of the CARES Act in prospective periods
may differ from our estimate as of March 28, 2020 due to changes in interpretations and assumptions, guidance that may be
issued and actions the Company may take in response to the CARES Act. The CARES Act is highly detailed, and the Company will
continue to assess the impact that various provisions will have on its business.
Net Loss Per Share
Basic loss per share for the Company is computed
by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted loss per share
includes the dilutive impact of outstanding stock options and unvested restricted shares.
Translation of Foreign Currencies
All assets and liabilities of the Company’s
foreign subsidiaries, each of whose functional currency is in its local currency, are translated into U.S. dollars at the exchange
rate in effect at the end of the quarter and the income and expense accounts of these affiliates have been translated at average
rates prevailing during each respective quarter. Resulting translation adjustments are made to a separate component of stockholders’
equity within accumulated other comprehensive loss. Foreign exchange transaction gains and losses are included in the accompanying
interim, condensed consolidated statement of operations.
2020 Plan and COVID-19 Pandemic
The Company believes that its existing plan
will generate sufficient cash which, along with its existing cash and availability under its facilities, will enable it to fund
operations through at least the next 12 months. However, should the Company require additional cash, or should the impact from
the COVID-19 pandemic discussed below be more severe than expected, the Company would identify other cost reductions or seek additional
resources.
In March 2020, the COVID-19 outbreak was
declared a global pandemic and became widespread in the U.S. While our products are considered “essential” and our
distribution center located in California continues to operate, some of our customers have been impacted and, to the extent they
operated retail stores, have been required to close their stores and curtail operations. We began to see an impact on orders at
the end of March and may continue to see lower demand in the near term as governmental restrictions on businesses remain in place.
Due to the uncertainty with respect to when governmental restrictions may be lifted and the widespread nature of the pandemic,
we cannot currently predict how it will impact our business in the long term.
The Company is not currently aware of any
events or circumstances arising from the COVID-19 pandemic that would require us to update any estimates, judgments or materially
revise the carrying value of our assets or liabilities. The Company’s estimates may change, however, as events evolve and
additional information is obtained, and any such changes will be recognized in the consolidated financial statements.
Disaggregation of Revenue
The Company’s revenue is primarily
from distinct fixed-price product sales in the juvenile product market, to similar customers and channels utilizing similar types
of contracts that are short term in nature (less than one year). The Company does not sell service agreements or goods over a period
of time and does not sell or utilize customer financing arrangements or time-and-material contracts.
The following is a table that presents
net sales by geographical area:
|
|
For the
three months ended
|
|
|
|
March 28, 2020
|
|
|
March 30, 2019
|
|
United States
|
|
$
|
35,778
|
|
|
$
|
36,236
|
|
All Other
|
|
|
4,560
|
|
|
|
6,302
|
|
Net Sales
|
|
$
|
40,338
|
|
|
$
|
42,538
|
|
All Other consists of Canada, Europe,
South America, Mexico, Asia, and the Middle East.
Contract Balances
The Company does not have any contract
assets such as work-in-process or contract liabilities such as customer advances. All trade receivables on the Company’s
condensed consolidated balance sheets are from contracts with customers.
Contract Costs
Costs incurred to obtain a contract are
capitalized unless short term in nature. As a practical expedient, costs to obtain a contract that are short term in nature are
expensed as incurred. All contract costs incurred in the three months ended March 28, 2020 and three months ended March 30,
2019 fall under the provisions of the practical expedient and have therefore been expensed.
Bank
of America Credit Facility. On June 28, 2018, the Company and Summer Infant (USA), Inc., as borrowers,
entered into a Second Amended and Restated Loan and Security Agreement with Bank of America, N.A., as agent, the financial
institutions party to the agreement from time to time as lenders, and certain subsidiaries of the Company as guarantors, as
amended in January and March (as amended, the “Restated BofA Agreement”). The Restated BofA Agreement replaced
the Company’s prior credit facility with Bank of America, and provides for an asset-based revolving credit facility
with a letter of credit sub-line facility. As of March 28, 2020, total revolver commitments under the credit facility were
$48,000. The total borrowing capacity is based on a borrowing base, which is defined as 85% of eligible receivables plus the
lesser of (i) 70% of the value of eligible inventory or (ii) 85% of the net orderly liquidation value of eligible
inventory, less applicable reserves. The scheduled maturity date of loans under the Restated BofA Agreement is June 28,
2023 (subject to customary early termination provisions). As a result of the amendments made to the Restated BofA Agreement
in January and March 2020, (i) the definition of Financial Covenant Trigger Amount was modified, (ii) the lenders' aggregate
revolver commitments were reduced, (iii) the definition of EBITDA was amended to exclude certain fees and expenses, (iv) the Company is required to meet certain minimum net sales
amounts for each period of three consecutive fiscal months through the three-month period ending December 31, 2020, (v) the
Company is required to meet a certain minimum EBITDA (as defined in the Restated BofA Agreement) as of the end of each fiscal
month, calculated on a trailing 12-month period, (vi) the applicable margin and applicable unused line fee rate were
increased, and (vii) certain reporting requirements were modified.
All obligations under the Restated BofA
Agreement are secured by substantially all the assets of the Company, including a first priority lien on accounts receivable and
inventory and a junior lien on certain assets subject to the Term Loan lender’s first priority lien described below. Summer
Infant Canada Limited and Summer Infant Europe Limited, subsidiaries of the Company, are guarantors under the Restated BofA Agreement.
Proceeds from the loans were used to satisfy existing debt, pay fees and transaction expenses associated with the closing of the
Restated BofA Agreement and may be used to pay obligations under the Restated BofA Agreement, and for lawful corporate purposes,
including working capital.
Loans under the Restated BofA Agreement
bear interest, at the Company’s option, at a base rate or at LIBOR, plus applicable margins based
on average quarterly availability under the Restated BofA Agreement. Interest payments are due monthly, payable in arrears. The
Company is also required to pay an annual non-use fee on unused amounts, as well as other customary fees as are set forth in the
Restated BofA Agreement. The Restated BofA Agreement contains customary affirmative and negative covenants. Among other restrictions,
the Company is restricted in its ability to incur additional debt, make acquisitions or investments, dispose of assets, or make
distributions unless in each case certain conditions are satisfied. The Company is also required to meet certain financial covenants
through the end of fiscal 2020, specifically (a) a minimum net sales amount for each period of three consecutive fiscal months,
measured at the end of each month, and (b) a trailing, 12-month minimum adjusted EBITDA amount (as defined in the Restated BofA
Agreement), measured at the end of each fiscal month. In addition, if availability falls below the following amounts, a springing
covenant would be in effect requiring the Company to maintain a fixed charge coverage ratio at the end of each fiscal month of
at least 1.0 to 1.0 for the twelve-month period then ended: (i) $3,000 through May 31, 2020, (ii) $3,500 from June 1 through June
30, 2020, (iii) $3,750 from July 1 through August 31, 2020, (iv) $4,000 from September 1 through September 30, 2020, (v) $4,250
from October 1 through October 31, 2020, (vi) $4,500 from November 1 through November 30, 2020, and (vii) $5,000 at any time from
and after December 1, 2020.
The Restated BofA Agreement also
contains customary events of default, including a cross default with the Term Loan Agreement or the occurrence of a change of
control. In the event of a default, the lenders may declare all of the obligations of the Company and its subsidiaries under
the Restated BofA Agreement immediately due and payable. For events of default relating to insolvency and receivership, all
outstanding obligations automatically become due and payable without any action on the part of the lenders.
As of March 28, 2020, under the Restated
BofA Agreement, the rate on base-rate loans was 5.0% and the rate on LIBOR-rate loans was 3.5%. The amount outstanding on the Restated
BofA Agreement at March 28, 2020, was $28,063 and borrowing availability was $5,626.
The amendments executed in the three months
ended March 28, 2020 were evaluated, to determine the proper accounting treatment for the transactions. Accordingly, debt extinguishment
accounting was used to account for the reduction in the total revolver commitments under the credit facility, resulting in the
write off of $266 in remaining unamortized deferred financing costs during the three months ended March 28, 2020.
Subsequent to fiscal quarter end, on April
29, the Company entered into further amendments to the Restated BofA Agreement. See Note 8 for information regarding these amendments.
Term
Loan Agreement. On June 28, 2018, the Company and Summer Infant (USA), Inc., as borrowers, entered into a
Term Loan and Security Agreement with Pathlight Capital LLC, as agent, each lender from time to time a party thereto , and
certain subsidiaries of the Company as guarantors, as amended in January and March 2020 (as amended, the
“Term Loan Agreement”) providing for a $17,500 term loan (the “Term Loan”). Proceeds from the Term Loan
were used to satisfy existing debt, pay fees and transaction expenses associated with the closing of the Term Loan and may be used
to pay obligations under the Term Loan Agreement, and for lawful corporate purposes, including working capital. The Term Loan is
secured by a lien on certain assets of the Company, including a first priority lien on intellectual property, machinery and equipment,
and a pledge of (i) 100% of the ownership interests of domestic subsidiaries and (ii) 65% of the ownership interests
in certain foreign subsidiaries of the Company, and a junior lien on certain assets subject to the liens under the Restated BofA
Agreement described above. The Term Loan matures on June 28, 2023. Summer Infant Canada Limited and Summer Infant Europe Limited,
subsidiaries of the Company, are guarantors under the Term Loan Agreement. As a result of the amendments made to the Term Loan Agreement
in January and March 2020, (i) the definition of IP Advance Rate Reduction was modified,
(ii) the definition of Term Loan Borrowing Base was modified to deduct a specified equipment
reserve amount from the calculation of the borrowing base, (iii) the definitions of Financial Covenant trigger and EBITDA
were amended consistent with the Restated BofA Agreement, (iv) consistent with the Restated BofA Agrement, the Company is required
to meet certain minimum net sales amounts for each period of three consecutive fiscal months through the three-month period ending
December 31, 2020; and certain minimum EBITDA as of the end of each fiscal month, calculated on a trailing 12-month period, (v)
principal payments on the term loan were suspended for 2020, such payments to resume in March 2021, and (vi) certain reporting
requirements were modified. In addition, as described below, beginning March 10, 2020, the term loan began to bear additional interest,
to be paid in kind ("PIK interest") at annual rate of 4.0%.
The principal of the Term Loan is being
repaid, on a quarterly basis, in installments of $219, with the first installment having been paid on December 1, 2018, until
paid in full on termination. In connection with the March 2020 amendment, principal payments on the Term Loan were suspended for
2020, to resume in March 2021. The Term Loan bears interest at an annual rate equal to LIBOR, plus
9.0%. Interest payments are due monthly, in arrears. In addition, the Term Loan began to accrue PIK (payment in kind) interest
at an annual rate of 4.0% in March 2020, which interest will become payable upon the earlier to occur of (i) the repayment of the
Term Loan in full, (ii) a sale or merger of the Company, (iii) the occurrence of default or event of default under the Term Loan
Agreement, or (iv) the Company achieving adjusted EBITDA of $12 million (calculated on a trailing, 12-month basis). If, and only
if, the PIK interest becomes due and payable as a result of the Company achieving the adjusted EBITDA event noted in clause (iv),
then the Company will pay all PIK interest then due and thereafter, PIK interest will continue to accrue and be paid on each subsequent
anniversary of such event. Obligations under the Term Loan Agreement are also subject to a prepayment
penalty if the Term Loan is repaid prior to the third anniversary of the closing of the Term Loan.
The Term Loan Agreement contains customary
affirmative and negative covenants that are substantially the same as the Restated BofA Agreement. Consistent with the Restated
BofA Agreement, the Company is also required to meet certain financial covenants through the end of fiscal 2020, specifically (a)
a minimum net sales amount for each period of three consecutive fiscal months, measured at the end of each month, and (b) a trailing,
12-month minimum adjusted EBITDA amount (as defined in the Restated BofA Agreement), measured at the end of each fiscal month.
In addition, consistent with the Restated BofA Agreement, if availability falls below a specified amount as described above, then
the Company must maintain a fixed charge coverage ratio at the end of each fiscal month of at least 1.0 to 1.0 for the twelve-month
period then ended. The Term Loan Agreement also contains events of default, including a cross default with the Restated BofA Agreement
or the occurrence of a change of control. In the event of a default, the lenders may declare all of the obligations of the Company
and its subsidiaries under the Term Loan Agreement immediately due and payable. For events of default relating to insolvency and
receivership, all outstanding obligations automatically become due and payable without any action on the part of the lenders.
As of March 28, 2020, the interest
rate on the Term Loan was 10.6% of cash interest and 4.0% of PIK interest. The amount outstanding on the Term Loan at March 28, 2020 was $16,406.
Aggregate maturities related
to the Restated BofA Agreement and the Term Loan Agreement are as follows:
Fiscal Year ending:
|
|
|
|
2020
|
|
|
0
|
|
2021
|
|
|
875
|
|
2022
|
|
|
875
|
|
2023
|
|
|
42,719
|
|
Total
|
|
$
|
44,469
|
|
Unamortized debt issuance costs were $2,491
at March 28, 2020 and $2,398 at December 28, 2019, and are presented as a direct deduction of long-term debt on the consolidated
balance sheets.
Subsequent to fiscal quarter end, on April
29, the Company entered into further amendments to the Term Loan Agreement. See Note 8 for information regarding these amendments.
Due to the uncertainty with respect to
the duration of the COVID-19 pandemic and its impact on the U.S. economy in the short and long term, it is possible that demand
for our products may decrease and, as a result, we may be unable to meet the financial covenants under the Restated BofA Agreement
and Term Loan Agreement. In such a case, the Company would seek to mitigate such an impact through cost reductions, restructuring
its existing indebtedness, or amending or seeking relief from these covenants from its lenders.
Intangible assets consisted of the following:
|
|
March 28,
|
|
|
December 28,
|
|
|
|
2020
|
|
|
2019
|
|
Brand names
|
|
$
|
11,819
|
|
|
$
|
11,819
|
|
Patents and licenses
|
|
|
4,126
|
|
|
|
4,101
|
|
Customer relationships
|
|
|
6,946
|
|
|
|
6,946
|
|
Other intangibles
|
|
|
1,882
|
|
|
|
1,882
|
|
|
|
|
24,773
|
|
|
|
24,748
|
|
Less: Accumulated amortization
|
|
|
(11,974
|
)
|
|
|
(11,852
|
)
|
Intangible assets, net
|
|
$
|
12,799
|
|
|
$
|
12,896
|
|
The amortization period for the majority
of the intangible assets ranges from 5 to 20 years for those assets that have an estimated life; certain of the assets have
indefinite lives (brand names). Total of intangibles not subject to amortization amounted to $8,400 as of March 28, 2020 and
December 28, 2019.
5.
|
COMMITMENTS AND CONTINGENCIES
|
Leases
The Company leases office space and
distribution centers primarily related to its Riverside California, Canada, United Kingdom, and Hong Kong operations. In
connection with these leases, there were no cash incentives from the landlord to be used for the construction of leasehold
improvements within the facility. Our headquarters in Woonsocket, Rhode Island continues to be accounted for as a
sale-leaseback lease. Beginning in April 2020, the Company subleased a portion of its Riverside warehouse lease. The
sub-lease has an initial term of one year, with an option to extend on a month to month basis for the remainder of the head
lease. The Company will record the sublease income net of lease expense.
The Company identified and assessed the
following significant assumptions in recognizing the right-of-use asset and corresponding liabilities:
|
·
|
Expected lease term — The expected lease term includes both contractual lease periods and, when applicable, cancelable
option periods when it is reasonably certain that the Company would exercise such options. As of March 28, 2020, these leases had
remaining lease terms between 1.5 and 3.3 years. The Canada lease has one 5-year extension option that has also not been included
in the lease term.
|
|
·
|
Incremental borrowing rate — The Company’s lease agreements do not provide an implicit rate. As the Company
does not have any external borrowings for comparable terms of its leases, the Company estimated the incremental borrowing rate
based on secured borrowings available to the Company for the next 5 years. This is the rate the Company would have to pay if borrowing
on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment.
|
|
·
|
Lease and non-lease components — In certain cases the Company is required to pay for certain additional
charges for operating costs, including insurance, maintenance, taxes, and other costs incurred, which are billed based on both
usage and as a percentage of the Company’s share of total square footage. The Company determined that these costs are non-lease
components and they are not included in the calculation of the lease liabilities because they are variable. Payments for these
variable, non-lease components are considered variable lease costs and are recognized in the period in which the costs are incurred.
|
The components of the Company’s lease expense for the
three months ended March 28, 2020 and March 30, 2019 were as follows:
|
|
For the
three months ended
|
|
|
|
March 28, 2020
|
|
|
March 30, 2019
|
|
Operating lease cost
|
|
$
|
621
|
|
|
$
|
623
|
|
Variable lease cost
|
|
|
267
|
|
|
|
362
|
|
Total lease cost
|
|
$
|
888
|
|
|
$
|
985
|
|
Weighted-average remaining lease term
|
|
1.85 years
|
Weighted Average discount rate:
|
|
5.00%
|
Cash paid for amounts included in the measurement of the Company’s
lease liabilities were $662 and $648 for the three months ended March 28, 2020 and March 30, 2019 respectively.
As of March 28, 2020, the present value of maturities of
the Company’s operating lease liabilities were as follows:
Fiscal Year Ending:
|
|
|
|
2020
|
|
$
|
2,005
|
|
2021
|
|
|
2,136
|
|
2022
|
|
|
299
|
|
2024
|
|
|
143
|
|
2024
|
|
|
0
|
|
Less imputed interest
|
|
|
(216
|
)
|
Total
|
|
$
|
4,367
|
|
Subsequent to fiscal quarter end, on April 24, 2020, the Company
entered into an amendment to the lease for its Woonsocket headquarters. See Note 8 for information regarding this amendment.
Litigation
The Company is a party to various routine
claims, litigation and administrative complaints incidental to its business, including claims involving product liability, employee
matters and other general liability claims, most of which are covered by insurance. We are not aware of any such proceedings or
claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, results of operations
or financial condition.
|
6.
|
SHARE BASED COMPENSATION
|
The Company is currently authorized to
issue up to 1,700,000 shares for equity awards under the Company’s 2012 Incentive Compensation Plan (as amended, “2012
Plan”). Periodically, the Company may also grant equity awards outside of its 2012 Plan as inducement grants for new hires.
Under the 2012 Plan, awards may be granted
to participants in the form of non-qualified stock options, incentive stock options, restricted stock, deferred stock, restricted
stock units and other stock-based awards. Subject to the provisions of the plans, awards may be granted to employees, officers,
directors, advisors and consultants who are deemed to have rendered or are able to render significant services to the Company or
its subsidiaries and who are deemed to have contributed or to have the potential to contribute to the Company’s success.
The Company accounts for options under the fair value recognition standard. Share-based compensation expense, net of forfeitures, for the three months
ended March 28, 2020 and March 30, 2019 was a credit of $11 and expense of $48, respectively. Share based compensation
expense is included in general and administrative expenses.
The fair value of each option award is
estimated on the date of grant using the Black-Scholes option valuation model that uses the assumptions noted in the table below.
The Company uses the simplified method to estimate the expected term of the options, but used an estimate for grants of “plain
vanilla” stock options based on a formula prescribed by the Securities and Exchange Commission. Forfeitures are estimated
at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Share-based
compensation expense recognized in the consolidated financial statements is based on awards that are ultimately expected to vest.
As of March 28, 2020, there were 65,619
stock options outstanding and 13,669 unvested restricted shares outstanding.
During the three months ended March 28,
2020, the Company did not grant stock options or shares of restricted stock. The following table summarizes the weighted average
assumptions used for stock options granted during the three months ended March 30, 2019.
|
|
For the Three
Months Ended
March 30, 2019
|
|
Expected life (in years)
|
|
|
4.8
|
|
Risk-free interest rate
|
|
|
2.5
|
%
|
Volatility
|
|
|
66.9
|
%
|
Dividend yield
|
|
|
0
|
%
|
Forfeiture rate
|
|
|
23.8
|
%
|
As of March 28, 2020, there were
93,244 shares available to grant under the 2012 Plan.
|
7.
|
WEIGHTED AVERAGE COMMON SHARES
|
Basic and diluted earnings or loss per
share (“EPS”) is based upon the weighted average number of common shares outstanding during the period. Diluted weighted
average number of common shares outstanding also included common stock equivalents such as stock options and restricted shares.
The Company does not include the anti-dilutive effect of common stock equivalents in the calculation of dilutive common shares
outstanding. The computation of diluted common shares for the three months ended March 28, 2020 excluded 65,619 stock options
and 13,669 shares of restricted stock outstanding. The computation of diluted common shares for the three months ended March 30,
2019 excluded 115,179 stock options and 22,856 shares of restricted stock outstanding.
The Company has evaluated subsequent events
through the filing date of this Quarterly Report on Form 10-Q and determined that no subsequent events occurred that would
require recognition in the consolidated financial statements or disclosure in the notes thereto except as follows:
Amendments to Restated BofA Agreement
On April 29, 2020, the Company and
Summer Infant (USA), Inc., as borrowers and certain subsidiaries of the Company as guarantors, entered into Amendment No. 5
to the Restated BofA Agreement. The amendment modified the terms of the Restated BofA Agreement to (a) increase the
applicable margins; (b) add a LIBOR floor of 0.75% and (c) with respect to the financial covenants (i) for the months
ending April through August 2020, adjusted the minimum net sales amounts the Company must meet for each period of three
consecutive fiscal months, and (ii) for the months ending April through December 2020, adjusted the minimum EBITDA (as
defined in the Restated BofA Agreement) the Company must meet as of the end of each fiscal month, calculated on a trailing
12-month period.
Amendments to Term Loan Agreement
On April 29, 2020, the Company and
Summer Infant (USA), Inc., as borrowers, and certain subsidiaries of the Company as guarantors, entered into a letter
agreement amending Amendment No. 4 to the Term Loan Agreement. The letter agreement modified the terms
of Amendment No. 4 to the Term Loan Agreement to (a) add a LIBOR floor of 0.75% and (b) modify the financial covenants
consistent with Amendment No. 5 to the BofA Amendment.
Amendment to Lease
On April 24, 2020, Summer Infant (USA),
Inc. (“Summer USA”), a wholly-owned subsidiary of the Company, entered into the Third Amendment to Lease (the “Amendment”)
with Faith Realty II, LLC (the “Landlord”) dated March 24, 2009. The Landlord is a company owned by Jason Macari, a
former officer and director of the Company and a holder of more than ten percent of the Company’s outstanding common stock.
The Amendment modified the lease to, among other things, (i) extend the current term of the lease to June 2025, (ii) reduce the
premises occupied by Summer USA under the lease, (iii) reduce the annual base rent payments for the term of the lease and (iv)
provide Summer USA two options to extend the term of the lease for an additional period of five-year terms upon prior written notice.
Sublease of Warehouse Space
Effective April 1, 2020, the Company subleased
a portion of its warehouse located in Riverside, California. The initial term of the sublease is one year, and thereafter shall
continue on a month-to-month basis until the termination of the master lease or, if earlier, if terminated upon 30 days’
prior written notice of the Company or the sublessor. The Company will receive base rent of $83 per month for the initial term
of the sublease.